| Paul Jai Sekhri |
Paul Jai Sekhri founded ARIAD Pharmaceuticals, Inc. in 2003, where he worked as President & Chief Business Officer from 2003 to 2004 and Cerimon Pharmaceuticals, Inc. in 2004, where he worked as President & Chief Executive Officer from 2004 to 2009. Mr. Sekhri also currently works at vTv Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022, Compugen Ltd., as Chairman from 2017, Pharming NV, as Chairman, and various other companies. Mr. Sekhri also formerly worked at Lycera Corp., as President, Chief Executive Officer & Director from 2015 to 2019, Pharming Group NV, as Chairman from 2016 to 2023, Petra Pharma Corp., as Chairman, and various other companies. Mr. Sekhri received his undergraduate degree from the University of Maryland and undergraduate degree and graduate degree from the University of Maryland School of Medicine. |
| Eran Ophir |
Eran Ophir is currently the Chief Scientific Officer at Compugen Ltd. He has an undergraduate degree from Tel-Aviv University and a doctorate degree from Weizmann Institute of Science. |
| Zurit Levine |
Zurit Levine is currently the Vice President-Technology Innovation at Compugen Ltd. Prior to this role, Dr. Levine held positions as Director at Neviah Genomics Ltd. and Therapeutic Discovery Corp. Dr. Levine has an educational background that includes undergraduate, graduate, and doctorate degrees from Tel-Aviv University. |
| Michelle Mahler |
Michelle Mahler is currently the Chief Medical Officer at Compugen Ltd. and the Vice President-Clinical Development at C4 Therapeutics, Inc. She previously worked as the Chief Medical Officer at 1E Therapeutics. Dr. Mahler holds a doctorate degree from the University of the Witwatersrand. |
| Anat Cohen-Dayag |
Anat Cohen-Dayag is currently the President, Chief Executive Officer & Director at Compugen Ltd. She is also a Director at Compugen, Inc. (United States), Israel Advanced Technology Industries, Pyxis Diagnostics Ltd., and Pyxis Ltd. In the past, she served as an External Director at Ramot at Tel Aviv University Ltd., a Director at Gamida Cell Ltd., and Head of Research & Development at Mindsense Biosystems Ltd. Dr. Cohen-Dayag holds an undergraduate degree from Ben-Gurion University of the Negev and graduate and doctorate degrees from the Weizmann Institute of Science. |
| Kinneret Livnat-Savitsky |
Kinneret Livnat-Savitsky is currently the Chairman at ImmPACT-Bio Ltd. and serves as an Independent Director at Compugen Ltd., Director at Ramot at Tel Aviv University Ltd., Director at DreaMed Diabetes Ltd., and Director at Biomica Ltd. Previously, she held the position of Chief Executive Officer at BioLineRx Ltd. from 2012 to 2016 and at FutuRx Ltd. from 2017 to 2021. She also served as Chairman at KAHR Medical Ltd., Director at Hadasit Medical Research Services & Development Ltd., Director at Evogene Ltd. from 2010 to 2013, Independent Non-Executive Director at Nutritional Growth Solutions Ltd., and General Manager at BioJerusalem. Additionally, she was the General Manager at Bioline Innovations Jerusalem LP from 2004 to 2010. Dr. Livnat-Savitsky obtained a graduate and doctorate degree from Tel-Aviv University in 1997 and an undergraduate degree from The Hebrew University of Jerusalem in 1990. |
| Mathias Hukkelhoven |
Mathias Hukkelhoven is an Independent Director at Compugen Ltd. and an Independent Non-Executive Director at Centessa Pharmaceuticals Plc. He previously worked as the Chairman-Portfolio Stewardship at Novartis Pharmaceuticals Corp. and as the Senior VP-Global Head Drug Regulatory Affairs at Novartis Pharmaceuticals Corp. from 2001 to 2009. He also served as the SVP-Global Regulatory, Safety & Biometrics at Bristol-Myers Squibb (Israel) Ltd. from 2010 to 2021. Dr. Hukkelhoven obtained his undergraduate and doctorate degrees from Radboud University Nijmegen. |
| Gilead Halevy |
Gilead Halevy founded Kedma Capital SHE LTD in 2006, where he is working as Founding Partner from 2013. Mr. Halevy also currently works at Continuity Software, Inc., as Chairman, Carmel Winery Ltd., as Chairman, Carmel Corp. Ltd., as Chairman from 2022, Zriha Hlavin Industries Ltd., as Chairman, Compugen Ltd., as Independent Director from 2018, Iskoor Metal & Steels Ltd., as Director, Bnext Ltd., as Director, Bs Brosh Projects Construction Ltd., as Director, Pelegas Ltd., as Director, Grand Ofek Projects Ltd., as Director, Kcps Steel Holdings Ltd., as Director, Solpaz Industries 1996 Ltd., as Director, R. Brand Stainless Steel (1991) Ltd., as Director, S.Al Holdings Ltd., as Director, Iskoor Finance Services Ltd., as Director, and White & Case LLP. Mr. Halevy also formerly worked at Brand Group (M.G) Ltd., as Chairman, CARMOR-Integrated Vehicle Solutions Ltd., as Chairman, Marina Galil Group Ltd., as Vice Chairman, Hatehof Industries Ltd., as Vice Chairman, Plas-Fit Ltd., as Chairman, Gilat Satellite Networks Ltd., as Director in 2011, Giza Venture Capital, as Director from 2001 to 2006, and Zellermayer, Pelossof, Rosovsky, Tsafrir Toledano & Co., as Senior Associate from 1993 to 1998. Mr. Halevy received his undergraduate degree and graduate degree from The Hebrew University of Jerusalem. |
